ARCHIVES

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

Major Changes Being Considered By NCI For FCRA

April 14, 1978

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001

In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting

January 14, 1983

Cancer Control Budget Still $4 Million Short

January 28, 1977